Endocrine Dysfunction and Quality of Life After Subarachnoid Hemorrhage

This study has been completed.
Information provided by (Responsible Party):
Erik Kronvall, Lund University Hospital
ClinicalTrials.gov Identifier:
First received: April 8, 2010
Last updated: September 6, 2012
Last verified: September 2012
Investigation of the incidence of endocrine dysfunction following subarachnoid hemorrhage (SAH), and to see if this has a relation to CNS lesions as evaluated by MRI and to common symptoms after SAH such as general exhaustion, lack of initiative, increased sleep demand and reduced quality of life.

Endocrine Dysfunction
Cerebral Infarctions
Quality of Life

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Endocrine Dysfunction and Quality of Life After Subarachnoid Hemorrhage

Resource links provided by NLM:

Further study details as provided by Lund University Hospital:

Biospecimen Retention:   None Retained
Blood and urine samples

Estimated Enrollment: 50
Study Start Date: November 2006
Study Completion Date: September 2012
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Patients with subarachnoid hemorrhage


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients from the southern part of Sweden who have suffered subarachnoid hemorrhage and admitted to the Department of Neurosurgery in Lund

Inclusion Criteria:

  • acute aneurysmal subarachnoid hemorrhage

Exclusion Criteria:

  • unable to give informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01101711

Department of Neurosurgery
Lund, Sweden
Sponsors and Collaborators
Lund University Hospital
  More Information

No publications provided

Responsible Party: Erik Kronvall, Dr., Lund University Hospital
ClinicalTrials.gov Identifier: NCT01101711     History of Changes
Other Study ID Numbers: 65/2006 
Study First Received: April 8, 2010
Last Updated: September 6, 2012
Health Authority: Sweden: Swedish National Council on Medical Ethics

Additional relevant MeSH terms:
Cerebral Infarction
Subarachnoid Hemorrhage
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Intracranial Hemorrhages
Nervous System Diseases
Pathologic Processes
Vascular Diseases

ClinicalTrials.gov processed this record on February 08, 2016